Apoptosis
Researchers at Daegu Catholic University in Gyeongsan, South Korea, have made a breakthrough discovery in the fight against ovarian cancer. The team found that a compound called corylin, derived from the fruit of a plant, exhibits significant anticancer activity by inducing apoptosis and cell cycle arrest in ovarian cancer cells.
Apoptosis
Researchers at Shaqra University in Saudi Arabia have made a significant discovery in the field of rheumatoid arthritis (RA) treatment. According to their study, published in the International Journal of Rheumatic Diseases, the team has identified a group of plant-derived compounds that can modulate both inflammation and apoptosis in RA,
Apoptosis
Researchers have made significant progress in understanding the immunogenicity of tislelizumab, a humanized anti-PD-1 antibody, which has been analyzed in a comprehensive study involving 3815 patients. The investigation focused on the incidence of anti-drug antibodies (ADAs) and the feasibility of assessing the suitability of validation cut points (VCPs) using statistical
Cytological research
A new study has identified a potential therapeutic strategy for glioma treatment. According to the research, malignant gliomas are characterized by invasive and infiltrative behavior, which can be attributed to proteases such as MMP-2. The study found that RNAi-mediated downregulation of MMP-2 induces apoptosis in human glioma xenograft cells by
Cytological research
A recent study published in Current Neurovascular Research has shed new light on the mechanisms underlying cerebral microvascular complications in primary diabetic encephalopathy. Researchers from Louisiana State University Health Sciences Center discovered that carbonyl stress, induced by methylglyoxal, plays a significant role in human brain endothelial cell apoptosis. The study
Cytological research
Researchers at Sichuan University in China have made a breakthrough in the fight against lung cancer by identifying a potential therapeutic target gene, DRR1. According to a study published in Oncology Reports, the DRR1 gene has been shown to have potent growth-suppressing properties in non-small cell lung cancer (NSCLC). The
Cytological research
Recent research has shed light on the effectiveness of arsenic trioxide (ATO) in treating acute promyelocytic leukemia (APL), a blood cancer that affects approximately 1,500 patients in the United States each year. The standard treatment for APL has been based on the combined administration of all-trans retinoic acid and
Cytological research
Research published in Chemico-biological Interactions reveals the anticancer properties of Cajanol, a compound derived from Pigeonpea roots. This study investigates the effects of Cajanol on human breast cancer cells, demonstrating its ability to induce apoptosis through a ROS-mediated mitochondrial pathway. The findings highlight the potential of Cajanol as a novel
Cytological research
Researchers from the University of Pittsburgh have made a groundbreaking discovery regarding the role of estrogen receptor-beta (ERβ) in lung cancer cells. According to their study published in Molecular Endocrinology, ERβ localized in the mitochondria plays a ligand-independent role in regulating apoptosis, a process essential for eliminating damaged or unwanted
Cytological research
A new report published by investigators in the United States has shed light on the potential therapeutic effects of blocking the angiotensin II type 1 receptor (AT1R) in human pancreatic cancer cells. The study, led by Q. Gong and colleagues at Thomas Jefferson University, reveals that the AT1R blocker losartan
Cytological research
Researchers at Vanderbilt University have made a groundbreaking discovery in the study of tumor necrosis factors. In a recent study published in the Journal of Biological Chemistry, the team led by R.S. Kenchappa found that the p75 neurotrophin receptor has a dual function in the development of the sympathetic
Cytological research
Scientists at Brown University have made a significant discovery in the field of cancer research by identifying a novel p53-inducible gene, TIGAR, which plays a crucial role in regulating glycolysis. TIGAR, short for TP53-induced glycolysis and apoptosis regulator, inhibits glycolysis by reducing cellular levels of fructose-2,6-bisphosphate. The researchers conducted
